XCF Global Prices Production Before the Maturity-Day Resale Ledger

Summary: XCF Global's Aug. 19 S-1 registers up to 212.770 million shares for resale against 411.677 million common shares outstanding as of Aug. 18. The filing includes debt-settlement shares already inside the denominator and only a subset of future default or conversion claims. The same issuer disclosed a $666,666 senior secured note funded at a $500,000 purchase price, with a maturity date of Aug. 20, 2026, a 5 million-share default reserve, and a 500,000-share commitment fee. The market is also being shown a post-period production claim of approximately 55,000 gallons of renewable diesel per day. The short disagreement is about whether new production becomes collected cash before the maturity and resale ledger becomes observable.

Scope: U.S. market, common-stock short opportunities only.

Status: Conditional Short Watchlist. The maturity date is immediate, but no payment, default, conversion, or completed resale has been verified. The reference-only 10/5 ratio fails because the credible squeeze case is much wider than 5%, and locate, borrow, recall, and exit-liquidity evidence remain incomplete.

Run time: 2026-08-21 01:39 Asia/Singapore. The selected market snapshot is a Nasdaq regular-session observation at 2026-08-20 13:37 ET.

Opportunity Ranking

Rank	Candidate	Direction	Mispricing	Evidence Freshness	Catalyst Window	Positioning	10/5 Status	Tradeability	Main Rejection Risk
1	SAFX	Short	A fresh resale ledger and a maturity-day secured note sit beside a post-period production claim, while the latest 10-Q shows $0.329 million cash, a $238.352 million working-capital shortage, and $383.760 million total liabilities.	Aug. 17 10-Q, Aug. 18 note 8-K, Aug. 19 S-1, Aug. 20 Nasdaq tape	Note maturity today, first payment/default filing, S-1 effectiveness, first holder resale, next cash and production filing	Latest public short interest was 5.828 million shares and 2.19 days to cover at July 31, but current borrow and recall are unknown.	Reject for execution; Watchlist for research. Reference-only base decline is greater than 10%, but the adverse squeeze case is much wider than 5%.	1.797 million shares traded versus 4.347 million average volume; displayed bid $0.3480 for 100 and ask $0.3487 for 82.	The 55,000-gallon daily delivery claim can become collected revenue, the note can be repaid or rolled, and holders may retain the registered shares.
2	CALC	Short	Stockholders approved the issuance path for 18.673 million Series A and 18.673 million Series B warrant shares, plus a 1-for-2 to 1-for-10 reverse split with proportionate authorized-share reduction.	Aug. 20 vote 8-K and Aug. 11 10-Q	First warrant exercise or resale, reverse-split implementation, next clinical and cash filing	503,070 shares of short interest at July 31 and 1.81 days to cover; current borrow and options remain unknown.	Watchlist. The claim stack is large, but $18.6 million cash and a clinical pipeline create a stronger counterparty.	949,936 shares traded against 1.479 million average volume; bid and ask sizes were 100 shares each.	Approval may improve listing optics, exercise proceeds may fund the company, and no exercise or resale may follow.
3	NIMU	Short	An Aug. 20 S-1/A updates a merger-linked preferred, secured-note, and warrant stack, including an $810,000 convertible note with a $2.95 conversion price.	Aug. 14 10-Q and Aug. 20 S-1/A	Merger closing, conversion, and resale registration	No reliable current Nasdaq quote or displayed market was returned in the live check.	Reject. The claim-state disagreement cannot be measured against a current executable market level.	Quote unavailable; no trade expression was underwritten.	A merger closing or private financing can change the wrapper before public supply appears.

Selected opportunity: SAFX, conditional short Watchlist.

Why this one now: It combines a dated maturity event, a fresh registration ledger, a balance sheet that cannot be reconciled to the current production story without new cash evidence, and a clear operating counterargument. A repository-wide and current-week duplicate scan found no prior SAFX article or signal. BIAF was excluded because it was already screened in the current week, and NXGL was the immediately preceding article.

What should surprise the reader: The 212.770 million S-1 number is not 212.770 million newly issued shares. Most of the ledger consists of shares already issued in debt settlements or private placements. The immediate question is narrower and more important: does the Aug. 20 note get paid, default, or convert, and do any of the registered holders actually sell after effectiveness?

Research query audit: I used mechanism-specific combinations including renewable fuel 25% original issue discount note maturity default shares resale registration, production ramp current cash working-capital shortage debt-settlement shares, Nasdaq warrant approval reverse split proportionate authorized reduction cash burn clinical pipeline, and merger S-1 convertible note preferred claims no current quote. Generic earnings queries were not used.

Why This Is the Best Opportunity Right Now

The selection is not based on the headline resale count. The S-1 is useful because it lets the reader reconstruct the ledger by economic state. It identifies already-issued shares from lenders, vendors, debt settlements, and private placements, then separately identifies shares that may be issued on default or conversion. It also states that the company receives no proceeds from selling-stockholder resales. The Aug. 19 S-1

The maturity date creates urgency. On Aug. 12, XCF entered a senior secured note with a $666,666 face amount and a $500,000 purchase price. The note bears 10% interest, matures Aug. 20, and carries 18% default interest. XCF also issued a 500,000-share commitment fee and agreed to reserve 5 million default shares. The filing states that the secured claim covers XCF's inventories, accounts, environmental attributes, deposit and securities accounts, equipment, and proceeds, but not the assets of its subsidiaries. The Aug. 18 8-K

The market has a real counterweight. An Aug. 18 company release says the Reno facility was delivering approximately 55,000 gallons of renewable diesel per day, the first sale since the facility resumed operations. That is management-disclosed operating evidence, not yet a filed cash-flow bridge. The distributed Aug. 18 release

The best current disagreement is therefore: a production claim may be arriving just as a secured cash obligation reaches maturity, while a resale statement makes the equity ledger visible. That combination can close the gap in either direction. It is a better short research setup than a generic dilution headline because the next state change is dated.

Why This Can Move More Than 5% Soon

The latest Nasdaq snapshot shows SAFX at $0.3486, up 1.69%, with a session range of $0.3451 to $0.3723. A maturity payment, default, conversion, registration effectiveness, or holder resale can change the market's interpretation of the common stock in one filing. A verified production collection, note payoff, or non-dilutive funding can create the opposite move.

The quote is only about 1% above the session low, and volume is below the reported average. That makes the catalyst observable but the current short expression poor. A greater-than-5% path is a discovery filter, not a permission to short a low-volume print.

10/5 Asymmetry Gate

The measurement basis is the $0.3486 reference price, not a verified entry.

Favorable base move: $0.3486 to $0.2700, approximately 22.6% underlying decline.
Credible adverse move: $0.3486 to $0.6500, approximately 86.5% underlying squeeze.
Reference-only probability-weighted price: 0.30 * $0.18 + 0.50 * $0.27 + 0.20 * $0.65 = $0.3190.
Reference-only expected short return: approximately 8.5% before borrow, fees, spread, slippage, recall, and gap costs.
Gross reward-to-adverse-risk: approximately 0.26:1, below the required 2:1 threshold.

10/5 status: Reject for current execution, Watchlist for research. The price-only map is useful for monitoring the maturity and resale states, but it does not prove a bounded adverse move or executable value.

What Should Surprise the Reader

The core surprise is not that XCF has debt. The 10-Q makes that obvious. It is that a production update can be economically real and still fail to solve a common-stock maturity problem.

The Aug. 19 S-1 lists 212.770 million shares for resale against 411.677 million common shares outstanding as of Aug. 18. That is a 51.7% registered-claim-to-current-denominator ratio, but it includes shares already issued to settle accounts payable, forbearance, private placements, and other obligations. The new Abri note contributes a separate 500,000 commitment fee, 5 million default reserve, and 6.667 million conversion claim. The ratio is a stress test, not current float.

The Setup

XCF operates the New Rise Reno renewable-fuel facility and describes a strategy centered on renewable diesel and sustainable aviation fuel. The latest 10-Q presents a weak filed operating base. For the six months ended June 30, revenue was $1.040 million, gross loss was $0.036 million, operating loss was $16.094 million, and net loss was $31.945 million. Net cash used in operating activities was $10.686 million. The June 30 10-Q

The balance sheet is more severe than the headline production claim. At June 30, XCF had $0.329 million cash, $124.245 million of current notes payable, $132.826 million of financial liability, $42.064 million accounts payable, and $77.171 million accrued and other current liabilities. Current liabilities were $250.934 million against current assets of $12.582 million, producing a reported working-capital shortage of $238.352 million. The filing says these conditions raise substantial doubt about going concern.

The 10-Q also says the Phillips 66 supply and offtake relationship had been terminated, that New Rise had repeated maintenance-related downtime, and that the company was temporarily producing renewable diesel while working toward SAF production. The Aug. 18 production announcement is newer evidence, but it remains a company release until the next filing shows volume, pricing, collections, gross margin, and cash.

The Market Price

Metric	Value	Interpretation
Latest regular-session price	$0.3486	Nasdaq snapshot at 2026-08-20 13:37 ET
Session change	+$0.0058 / +1.69%	Positive tape after the production announcement, not proof of cash conversion
Intraday high / low	$0.3723 / $0.3451	The latest quote is close to the session low
Volume	1,797,552 shares	About 41% of Nasdaq's 4,346,760 average-volume figure
Bid / ask	$0.3480 / $0.3487	Approximately 0.20% displayed spread before costs
Displayed bid / ask size	100 / 82 shares	Top-of-book depth is not exit-liquidity proof
52-week high / low	$1.55 / $0.1185	The common is volatile and remains exposed to discontinuous moves
Provider market capitalization	$143.211 million	Context only; the current claim and resale states remain unresolved
Latest reported short interest	5,827,798 shares	Nasdaq settlement data dated July 31, or about 1.4% of the Aug. 18 common count
Days to cover	2.19	Latest public short-interest snapshot, not live borrow availability

The market-data sources are the Nasdaq SAFX quote snapshot, Nasdaq summary, and Nasdaq short-interest snapshot. Nasdaq returned no usable listed option chain. I do not have sufficient reliable data to quantify current borrow cost, recall terms, dealer positioning, or full exit liquidity.

The Mispricing

The simple bearish version says that 212.770 million registered shares will be sold. That overstates the evidence.

The stronger state ladder is:

Current common denominator: 411.677 million shares outstanding as of Aug. 18.
Already-issued resale claims: shares issued for private placements, debt settlements, forbearance, consulting, and other obligations are included in the S-1 ledger and, in many cases, already inside the current denominator.
Maturity-day claim: the Abri note has a $666,666 face amount, a $500,000 purchase price, 500,000 commitment shares, and a 5 million default reserve. The filing also describes 6.667 million conversion shares.
Registration state: the Aug. 19 S-1 is filed, but no subsequent effectiveness record or completed holder resale was verified in the current SEC submissions check.
Operating state: XCF has announced daily deliveries, but the filed June 30 cash-flow statement predates that announcement and does not prove collected cash.

This is a financing-pressure thesis with a real operating counterargument. The market may be right to value the facility above the stale June 30 revenue line if deliveries are repeatable and paid. The market may be wrong if it treats an announced daily run rate as common cash while senior claims, current notes, accrued interest, and feedstock disputes remain unresolved.

The Positioning

The latest public short-interest record is not trivial but does not establish a crowded short. Nasdaq reported 5.828 million shares short at July 31, with 2.19 days to cover on the then-average volume. Against the Aug. 18 common count, that is about 1.4% of shares outstanding. Current borrow availability, cost, recalls, and locate status are unknown. Positioning score: 3/5.

The observable flow is mixed. The stock is up on the day, but current volume is below average and the latest quote is close to the session low. The S-1 says selling stockholders may sell all, some, or none of their shares at market or negotiated prices, and that XCF receives no proceeds from those resales. Several holders received shares for debt or obligations at prices that may be below the current quote, creating a potential supply incentive. That is a holder incentive, not proof of current selling.

The production announcement raises squeeze risk. If the 55,000-gallon claim becomes collected revenue and the note is paid, the market can treat the resale ledger as a capital cleanup rather than an immediate supply event. A positive customer agreement or a non-dilutive refinancing would be a stronger counterargument than a generic SAF narrative.

The Catalyst

Step	State as of this run	Cheapest test	Bearish interpretation	Squeeze or invalidation path
Abri note maturity	Face amount $666,666, purchase price $500,000, maturity Aug. 20, 2026	Payment, extension, default, or conversion filing	Default shares, default interest, or equity settlement makes the claim observable	Payment or refinancing removes the immediate cash clock
S-1 registration	Filed Aug. 19; effectiveness not verified	SEC effectiveness record	Holder resale becomes legally available	No effectiveness or holder retention keeps supply conditional
First holder resale	Not observed	Form 144, trade disclosure, or next share-count filing	Resale converts the ledger into market supply	No resale despite effectiveness weakens timing
Production-to-cash bridge	Aug. 18 release claims 55,000 gallons per day; filed cash data predates it	Next 8-K, 10-Q, invoice, collection, gross margin, and OCF evidence	Output does not cover senior claims and working-capital needs	Repeated deliveries, cash collections, and improving margins invalidate the short path
Phillips 66 and BGN state	P66 agreement terminated; BGN path and other customer work remain separate	Definitive customer, tolling, settlement, and feedstock documents	Commercial replacement remains uncertain	Binding offtake, feedstock, and financing create a positive rerating
Business combination and capital claims	S-1 contains merger and claim disclosures; closing state is not the maturity test	Next merger, financing, and common-denominator filing	Additional claims and expenses expand the common ledger	Closing funded on terms that reduce senior risk can squeeze the stock

The first falsification is the maturity filing. If the note is paid without new equity, the short thesis loses its nearest catalyst. If it defaults but no registration or resale follows, the claim remains a legal risk rather than an immediate tape event. If the S-1 becomes effective and a holder sells, the thesis becomes more observable.

The Payoff

The short case does not require the Reno facility to be worthless. It requires production and collection to lag the obligations senior to common equity, while registered holders gain a route to sell claims issued at lower prices.

The base case assumes the note is paid, rolled, or settled without a clean operating-cash inflection, the S-1 remains a visible supply overhang, and the market tests the lower part of the recent range. The top case assumes a maturity problem or actual resale arrives before the production announcement becomes a filed cash-flow bridge. The bottom case assumes the production claim converts into cash, the note is resolved, and holders retain stock while the market prices a commercial ramp.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Horizon	Conditions	Evidence Quality
Top Case for the short	30%	$0.18	-48.4% underlying	Days to 8 weeks	Maturity or default becomes observable, S-1 effectiveness or first resale arrives, and production cash does not cover the claim stack	Medium. Maturity and claims are filed; payment and resale are unknown
Base Case	50%	$0.27	-22.6% underlying	2-8 weeks	Note is paid or extended, S-1 remains an overhang, production is not yet reconciled to cash, and no binding non-dilutive rescue appears	Medium
Bottom Case for the short	20%	$0.65	+86.5% squeeze	Days to 8 weeks	55,000-gallon deliveries become collected cash, the note is repaid or refinanced, customers or BGN provide funded support, and holders retain claims	Medium-low. The production claim is recent and management-sourced
Invalidation	n/a	$0.75 or higher with collected cash	n/a	Any time	A filed cash bridge, paid maturity, non-dilutive funding, and sustained production remove the near-term maturity-supply disagreement	Medium

Probability-weighted expected value: Reference-only weighted price is $0.3190, implying approximately 8.5% expected short return before costs. Executable after-cost EV cannot be computed because locate, borrow, recall, depth, exit liquidity, and gap costs are unverified.

Current market level and timestamp: $0.3486, Nasdaq regular session, 2026-08-20 13:37 ET.

Primary instrument: SAFX common stock, only if every short-side gate is independently verified.

10/5 favorable base move: 22.6% from the reference level, not a verified entry.

10/5 credible adverse move: 86.5% from the reference level.

10/5 measurement basis: Reference-only.

10/5 status: Reject for execution, Watchlist for research.

Confidence: Medium for the filed liability and claim-state bridge, low for the maturity outcome and near-term price path.

The Kill Shot

The strongest mature counterparty argument is that XCF has now moved from commissioning to commercial delivery. If 55,000 gallons per day is repeatable, customers pay promptly, and production margins are positive, the company may be able to resolve a $666,666 bridge note without issuing the reserved default shares. The S-1 would then describe a large legacy ledger, not an immediate new supply event.

The load-bearing assumption is that the maturity-day cash problem will produce a visible default, conversion, or resale before collections and refinancing improve. That assumption is fragile. The note is small relative to a successful production ramp, and the Aug. 18 operating announcement is exactly the type of new evidence that can overpower a stale June 30 balance sheet.

The market may already know the short case. The S-1 is public, the latest short-interest figure is available, and the stock trades well below its 52-week high. There is no edge in repeating that the company has debt. The differentiated claim is the timing bridge between the maturity date, the specific default reserve, registration effectiveness, actual resale, and filed cash conversion.

The trade can lose even if the balance-sheet thesis is directionally right. The note can be paid or rolled. A short can be recalled before the S-1 becomes effective. A production or customer headline can gap the stock above a stop. The S-1 can remain ineffective while the common trades on scarcity. Thin displayed depth can make a correct exit impossible at the reference price.

What Could Go Wrong

XCF pays or refinances the Abri note without issuing default shares.
The 55,000-gallon daily delivery claim becomes repeatable, collected revenue and positive operating cash.
A binding customer, tolling, feedstock, or non-dilutive financing agreement replaces the terminated Phillips 66 route.
The S-1 remains ineffective or registered holders retain their shares.
A merger or strategic financing reduces senior claims and produces a short-covering rally.
A borrow recall, halt, or low-depth tape forces a cover before the filing thesis is tested.

What Would Prove This Wrong

The next filing or lender notice shows the Aug. 20 note was paid or refinanced with no new common claim.
The S-1 becomes effective but the first holder and denominator records show no meaningful resale.
The next cash-flow filing reconciles repeated renewable-diesel deliveries to collected revenue, positive gross margin, and a material reduction in operating cash use.
XCF files a binding offtake or tolling agreement with funded terms and a credible feedstock and working-capital plan.
SAFX sustains a move above $0.75 with fresh volume and collected-cash evidence while the resale ledger remains untraded.

Risk Audit

Risk	Why it matters	Control
Maturity state	The note matures on the current date, but payment, default, and conversion are not yet filed	Do not assume default; check the next 8-K, lender notice, and share-count filing
Registration state	The S-1 is filed, but effectiveness and resale are unknown	Keep 212.770 million as a potential resale ledger, not current float
Operating counterargument	55,000 gallons per day could create real cash after the June 30 reporting cut	Require collected revenue, margin, and OCF evidence before increasing short conviction
Senior claims	Current notes, financial liability, accrued liabilities, and accounts payable rank ahead of common	Reconcile payment priority, subsidiary guarantees, collateral, and cash separately
Borrow and recall	Short interest is dated and borrow cost is unavailable	No-locate/no-trade; no position without current securities-lending confirmation
Quote and liquidity	The reference is close to the session low; displayed depth is only 100 bid and 82 ask shares	Do not short the low; require fresh spread, depth, venue, volume-quality, and exit-liquidity checks
Gap and halt	A maturity or production filing can reprice the stock discontinuously	Avoid market orders, leverage, margin, and unsupported options expressions
Claim arithmetic	Registered shares include issued debt settlements and conditional default or conversion claims	Reconcile current denominator, actual resale, and future issuance without double-counting

Best Trade Strategy

Direction: Conditional common-stock short Watchlist only. There is no executable short in this run.

Entry: null. Reassess only after the maturity state is filed, the S-1 effectiveness or completed resale is verified, the fresh quote is not near the session low, and locate, borrow cost, recall terms, spread, depth, venue quality, volume quality, and exit liquidity all pass.

Targets: Reference map only: $0.18 top case, $0.27 base case, and $0.65 bottom case. These are not price instructions.

Horizon: Days to eight weeks around the Aug. 20 maturity, the first post-maturity filing, S-1 effectiveness, first holder resale, and the next production-to-cash disclosure.

Invalidation: Cover or remove the Watchlist if the note is paid or refinanced, production becomes collected positive-margin cash, a funded offtake or non-dilutive financing closes, or the stock sustains above $0.75 with operating confirmation.

No-locate/no-trade conditions: No locate; punitive or unstable borrow; missing recall terms; quote at a halt or session low; no maturity/default evidence; unverified S-1 effectiveness; no evidence that registered holders are selling; missing spread, depth, venue, volume quality, or exit liquidity; a binding funded production update; or any options, leverage, margin, or market-order expression without verified terms.

Monitoring: Check the SEC submissions record, Abri payment/default or extension evidence, S-1 effectiveness, the first Form 144 or completed resale, the next common-share filing, production invoices and collections, gross margin, OCF, P66 settlement, BGN terms, and merger-related financing.

Sources

Source	Date / timestamp	Use
XCF Global Form S-1	Filed Aug. 19, 2026	212.770 million resale ledger, Aug. 18 common denominator, debt-settlement shares, Abri claims, operating risks, and no issuer proceeds from resale
XCF Global Aug. 18 Form 8-K	Filed Aug. 18, 2026	$666,666 face note, $500,000 purchase price, Aug. 20 maturity, 500,000 commitment shares, 5 million default reserve, and collateral
XCF Global June 30 Form 10-Q	Filed Aug. 17, 2026	Cash, working-capital shortage, liabilities, revenue, net loss, operating cash flow, production history, and senior claims
XCF Global Aug. 18 production release	Aug. 18, 2026	Company announcement of approximately 55,000 gallons per day and first post-restart sale; not an audited cash-flow filing
SEC SAFX submissions	Checked Aug. 20, 2026	Current filing-state check; no later maturity/default or effectiveness record was found in the current submissions list
Nasdaq SAFX quote	Aug. 20, 2026, 13:37 ET	Price, change, bid, ask, displayed sizes, volume, and timestamp
Nasdaq SAFX summary	Aug. 20, 2026, 13:36 ET	Session range, average volume, market-cap context, and 52-week range
Nasdaq SAFX short interest	Settlement July 31, 2026	Latest reported short interest and days to cover; not current borrow availability
Nasdaq SAFX option-chain check	Checked Aug. 20, 2026	No usable listed chain returned in the current check
CalciMedica Aug. 20 vote 8-K	Filed Aug. 20, 2026	Ranked candidate: approved warrant issuance and reverse-split authority
CalciMedica June 30 Form 10-Q	Filed Aug. 11, 2026	Ranked candidate: cash, operating cash use, clinical financing, and current denominator
NIMU Aug. 20 S-1/A	Filed Aug. 20, 2026	Ranked candidate: merger-linked preferred and convertible claim state

Research Quality Scorecard

Criterion	Score	Reason
Market disagreement	5	A dated maturity and resale ledger conflict with a fresh production-to-sales claim.
Evidence base	5	The core liability, cash, claim, note, and operating facts come from Aug. 17-19 SEC filings and the Aug. 20 Nasdaq tape.
Positioning and flows	3	July 31 short interest and live top-of-book are observed, but current borrow, recall, dealer, fund, and full-depth data are missing.
Catalyst path	5	Maturity, payment/default, registration effectiveness, first resale, and cash reconciliation are observable steps.
Payoff architecture	3	Price-only targets are defined, but the adverse production and squeeze case is wide and entry is null.
Invalidation discipline	5	Payment, refinancing, collections, binding offtake, holder retention, and price-plus-cash conditions are explicit.
Differentiated insight	5	The article separates an issued resale ledger from the maturity-day default/conversion claims and the post-period production announcement.
Client value	4	The sequence remains useful even if no short is executable.

Total: 35 / 40. The evidence supports publishable research, but the classification remains a conditional Watchlist and the current short fails the 10/5 and execution gates.

Bottom Line

SAFX is not an executable short at the current print. It is a maturity-day test of whether a renewable-fuel production story can generate collected cash before senior claims and a visible resale ledger pressure the common stock. The S-1 is not current float, the production announcement is not filed cash conversion, and the note's payment or default state is not yet verified. Wait for the state transition.

Illustration Prompt

Create a realistic, high-value, high-end elite, beautiful master editorial illustration for The Mispricing Desk about XCF Global (SAFX) pricing renewable-diesel production before a maturity-day resale ledger. Stage a dark institutional fuel terminal control room with a polished graphite desk. In the foreground place three precise documents: 411.677M COMMON SHARES, 212.770M RESALE LEDGER, and AUG 20 NOTE MATURITY, beside a secured-lender stamp reading $666,666 FACE / $500,000 PURCHASE. Behind the papers, show a restrained Reno refinery loading rack with a tanker marked 55,000 GAL/DAY CLAIM, but place a transparent cash-flow ruler over it reading $0.329M CASH and $10.686M H1 OCF USE. Add a thin brass timeline from MATURITY to EFFECTIVENESS to FIRST RESALE, with a small order-book panel showing 100 BID / 82 ASK. Use graphite, oxidized steel, muted fuel-amber, deep navy, bone paper, and restrained crimson. The mood is forensic, calm, and high-stakes without spectacle, like a Bloomberg Markets, Barron's, or The Economist cover. Avoid generic candlesticks, rockets, dollar bills, or celebratory green arrows. Include a subtle but readable watermark or etched text reading The Mispricing Desk.